Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Case Report

Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin

Authors: E. Fidan, M. Fidan, F. Ozdemir, H. Kavgaci, F. Aydin

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

Toxic epidermal necrolysis (TEN) is a rare dermatological disease that causes serious morbidity and mortality. It may be caused by antibiotics, anticonvulsants, nonsteroidal anti-inflammatory agents, allopurinol, infections, autoimmune diseases, and radiotherapy. A 49-year-old man was admitted to our hospital because of skin changes. Prophylactic phenytoin was administered, and cranial radiotherapy was planned for brain metastases. During these treatments, erythematous lesions and blisters were observed on his scalp, face, neck, the front and back of his body, and his arms. Detachment of the skin, especially on the back, was also observed. TEN was diagnosed, and phenytoin was discontinued. Methylprednisolone 80 mg/day IV and intravenous immunoglobulin 1 g/kg/day were applied for treatment. After 10 days, skin recovery and re-epithelialization were established, temperature decreased, and mucosal hemorrhage ceased. The patient was discharged after 2 weeks.
Literature
1.
go back to reference Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell’s disease). Burns. 2010;36(2):152–63.PubMedCrossRef Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell’s disease). Burns. 2010;36(2):152–63.PubMedCrossRef
2.
go back to reference Mittmann N, Chan BC, Knowles S, Shear NH. IVIG for the treatment of toxic epidermal necrolysis. Skin Therapy Lett. 2007;12(1):7–9.PubMed Mittmann N, Chan BC, Knowles S, Shear NH. IVIG for the treatment of toxic epidermal necrolysis. Skin Therapy Lett. 2007;12(1):7–9.PubMed
3.
go back to reference Fernández FA, Pintor E, Quesada R, Garcés FJ. Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy. Actas Dermosifiliogr. 2007;98(7):483–5.PubMedCrossRef Fernández FA, Pintor E, Quesada R, Garcés FJ. Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy. Actas Dermosifiliogr. 2007;98(7):483–5.PubMedCrossRef
4.
go back to reference Sarma N. Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermatol. 2009;10(4):264–7.PubMedCrossRef Sarma N. Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermatol. 2009;10(4):264–7.PubMedCrossRef
5.
go back to reference Trent JT, Bowes LE, Romanelli P, Kerdel FA. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation. J Cutan Med Surg. 2001;5(6):475–8.PubMedCrossRef Trent JT, Bowes LE, Romanelli P, Kerdel FA. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation. J Cutan Med Surg. 2001;5(6):475–8.PubMedCrossRef
6.
go back to reference Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol. 2004;43(1):67–73.PubMedCrossRef Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol. 2004;43(1):67–73.PubMedCrossRef
7.
go back to reference Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol (2004) Jan;43(1):67–73. Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol (2004) Jan;43(1):67–73.
8.
go back to reference Oner Dincbas F, Yörük S, Demirkesen C, Uzel O, Koca S. Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment. Onkologie. 2004;27(4):389–92.PubMedCrossRef Oner Dincbas F, Yörük S, Demirkesen C, Uzel O, Koca S. Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment. Onkologie. 2004;27(4):389–92.PubMedCrossRef
9.
go back to reference Aguiar D, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol. 2004;66(3):345–50.PubMedCrossRef Aguiar D, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol. 2004;66(3):345–50.PubMedCrossRef
10.
go back to reference Metro G, Pino S, Pellegrini D, Sacerdoti G, Fabi A. Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis. Anticancer Res. 2007;27(2):1167–9.PubMed Metro G, Pino S, Pellegrini D, Sacerdoti G, Fabi A. Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis. Anticancer Res. 2007;27(2):1167–9.PubMed
11.
go back to reference Yang Y, Xu J, Li F, Zhu X. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Int J Dermatol. 2009;48(10):1122–8.PubMedCrossRef Yang Y, Xu J, Li F, Zhu X. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Int J Dermatol. 2009;48(10):1122–8.PubMedCrossRef
Metadata
Title
Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin
Authors
E. Fidan
M. Fidan
F. Ozdemir
H. Kavgaci
F. Aydin
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9864-5

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.